Immediate Impact
2 standout
Citing Papers
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies
2020 Standout
Works of Eric Assenat being referenced
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial
2023
A multicenter phase Ib-IIR trial assessing the activity of regorafenib combined with modified gemcitabine: Oxaliplatin (mGEMOX) in patients with advanced biliary tract cancer (aBTC).
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Eric Assenat | 16 | 3 | 11 | 6 | 3 | 23 | ||
| Yurii Ostapenko | 8 | 2 | 8 | 4 | 4 | 15 | ||
| Friedrich Sinner | 16 | 6 | 28 | 3 | 3 | 35 | ||
| Cuncai Zhou | 15 | 5 | 2 | 21 | 8 | 3 | 30 | |
| Saad Tahir | 23 | 3 | 3 | 10 | 4 | 29 | ||
| Alba Kostandini | 7 | 9 | 16 | 6 | 2 | 29 | ||
| Laura Mattheis | 5 | 1 | 4 | 3 | 3 | 18 | ||
| Douglas B. Johnson | 28 | 1 | 3 | 2 | 11 | 3 | 33 | |
| James C. Patti | 13 | 16 | 5 | 5 | 3 | 25 | ||
| Nimali Fernando | 4 | 6 | 2 | 14 | 2 | 33 | ||
| Gloryanne Aidoo-Micah | 7 | 1 | 3 | 5 | 3 | 18 |
All Works
Loading papers...